Figure 2.
Serum TARC levels. Serum TARC levels were measured by ELISA prior to initiation of treatment of primary disease and at diagnosis of R/R cHL, at end-of-treatment (EOT) of R/R disease and during follow-up (FU). Values above 880 pg/ml were considered elevated based on previous findings (28). TARC levels decreased during treatment and were still normal at the last follow-up moment.